(PharmaNewsWire.Com, April 13, 2017 ) As per the syndicated report published by Market Data Forecast Europe Stem Cell Market which is estimated to be USD 4.11 billion in 2016 is poised to reach USD 7.92 billion by 2021, at a CAGR of 14% from 2016 to 2021. It can be attributed to the factors such as increasing prevalence of cancer and cardiac, neurological, and musculoskeletal disorders, rise in cognizance for prompt diagnosis, rising number of Stem Cell techniques, and improving healthcare infrastructure in developing markets. However certain challenges like stringent government laws, improper facilities and lack in skilled personnel must be dealt with to attain the full potential.
The allogeneic stem cell therapy is predicted to account for the largest share of the market in 2016. The market is expected to grow rapidly due to the extensive research and development being done in the sector. In the life sciences field, one of the most blooming markets at the moment is the stem cell market and is forecasted to grow exponentially in the upcoming years as stem cells help in cost-effective treatment of many ailments that currently have no or ineffective treatments.
Regenerative medicines are one of the most important use of stem cells, and other major areas include oncology, orthopaedics, haematology, neurology and cardiology. Another widely found application is drug discovery as well as development. Stem cells are a kind of research tool, as the in vitro study allows scientists to understand the role of various organs in depth and the development of particular illnesses; stem cells may also probably allow drug developers to test emerging therapies on the diseased cells. Stem cells therapy has been showing substantial potential in treatment of cancer successfully. Cancer stem cells which have been tested on animals have shown satisfactory results.
Europe Stem Cell Market is segmented based on type, application, mode of treatment and technology as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Based on Type: Adult Stem Cells Human Embryonic Cells Pluripotent Stem Cell Natural Rosette Cells Based on Application: CNS CVS GIT Regenerative Medicine Musculoskeletal Eye & Immune System Development Blood Disorders Based on Mode of Treatment: Autologous Allogeneic Based on Technology: Cell Acquisition Cell Production Cryopreservation Expansion Sub-Culture
Europe is an amalgamation of major economies like Germany, Spain, Italy, U.K. and France among others to name a few. The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well (Rest of Europe). As per the study France is poised to hold the major market share while Germany is the fastest growing market in this region.
Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc are the major players operating in the Europe Stem Cell Market. According to recent reports StemCells Inc has merged with Israeli medical devices firm, Microbot Medical, thus strengthening their hold in the market.
The Stem Cell market study offers the following deliverables: Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Biotechnology Segment:
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
